FDA Announces Joint Meeting of Advisory Committees for Public Comment

Summary

The FDA is hosting a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee, inviting public input on regulatory issues, and establishing a public docket for comments.